SAVA Q3 2020 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$399,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$228,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$1M

Stockholders' Equity

$24M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$104	-100.0%
Gross Profit	-$399,000	$52	-767407.7%
Operating Income	-$1M	-$779,000	-84.5%
Net Income	-$1M	-$697,000	-105.2%